Applied Therapeutics Inc (APLT)

$5.14

-0.12

(-2.28%)

Market is closed - opens 7 PM, 22 Jul 2024

Performance

  • $5.08
    $5.35
    $5.14
    downward going graph

    1.1%

    Downside

    Day's Volatility :4.98%

    Upside

    3.93%

    downward going graph
  • $1.18
    $9.39
    $5.14
    downward going graph

    77.04%

    Downside

    52 Weeks Volatility :87.43%

    Upside

    45.26%

    downward going graph

Returns

PeriodApplied Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
16.55%
6.4%
0.0%
6 Months
86.91%
6.0%
0.0%
1 Year
275.18%
9.6%
0.0%
3 Years
-74.26%
14.8%
-19.4%

Highlights

Market Capitalization
601.0M
Book Value
$0.59
Earnings Per Share (EPS)
-1.91
Wall Street Target Price
11.4
Profit Margin
0.0%
Operating Margin TTM
-11101.58%
Return On Assets TTM
-51.57%
Return On Equity TTM
-612.33%
Revenue TTM
-477.0K
Revenue Per Share TTM
0.0
Quarterly Revenue Growth YOY
-98.2%
Gross Profit TTM
0.0
EBITDA
-74.8M
Diluted Eps TTM
-1.91
Quarterly Earnings Growth YOY
0.0
EPS Estimate Current Year
-1.17
EPS Estimate Next Year
-0.46
EPS Estimate Current Quarter
-0.16
EPS Estimate Next Quarter
-0.18

Analyst Recommendation

Buy
    90%Buy
    9%Hold
    0
    0%Sell
Based on 11 Wall street analysts offering stock ratings for Applied Therapeutics Inc(by analysts ranked 0 to 5 stars)
Based on 11 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
10
10
8
Hold
1
1
1
Sell
00
00
00

Analyst Forecast

What analysts predicted

Upside of 121.79%

Current $5.14
Target $11.40

Technicals Summary

Sell

Neutral

Buy

Applied Therapeutics Inc is currently in a neutral trading position according to technical analysis indicators.

Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Applied Therapeutics Inc
Applied Therapeutics Inc
15.51%
86.91%
275.18%
-74.26%
-75.08%
Moderna, Inc.
Moderna, Inc.
-9.87%
21.5%
-2.91%
-60.58%
762.21%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
1.84%
12.81%
47.11%
81.12%
258.69%
Novo Nordisk A/s
Novo Nordisk A/s
-6.7%
24.69%
59.95%
200.63%
443.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
4.28%
11.69%
35.86%
150.1%
182.38%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Applied Therapeutics Inc
Applied Therapeutics Inc
NA
NA
NA
-1.17
-6.12
-0.52
NA
0.59
Moderna, Inc.
Moderna, Inc.
24.73
NA
0.0
-7.18
-0.38
-0.16
NA
33.47
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
31.53
31.53
1.46
44.41
0.15
0.08
NA
250.15
Novo Nordisk A/s
Novo Nordisk A/s
45.49
45.49
2.36
3.47
1.0
0.25
0.01
22.18
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
31.66
31.66
0.53
17.05
0.24
0.13
NA
71.8
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Applied Therapeutics Inc
Applied Therapeutics Inc
Buy
$601.0M
-75.08%
NA
0.0%
Moderna, Inc.
Moderna, Inc.
Buy
$46.5B
762.21%
24.73
-115.82%
Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
Buy
$117.5B
258.69%
31.53
29.45%
Novo Nordisk A/s
Novo Nordisk A/s
Buy
$589.9B
443.55%
45.49
36.55%
Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
Buy
$126.0B
182.38%
31.66
39.46%

Insights on Applied Therapeutics Inc

  • Vs NVO

    In the last 3 years, Novo Nordisk A/s has given 200.6% return, outperforming this stock by 274.9%

Institutional Holdings

  • Franklin Resources Inc

    9.25%
  • VR Adviser, LLC

    7.94%
  • Perceptive Advisors LLC

    7.01%
  • HHG PLC

    5.61%
  • Propel Bio Management LLC

    5.35%
  • Knoll Capital Management LP

    4.88%

Company Information

applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.

Organization
Applied Therapeutics Inc
Employees
26
CEO
Dr. Shoshana Shendelman Ph.D.
Industry
Biotechnology

FAQs